This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Jayex Technology Résultats passés

Passé contrôle des critères 0/6

Jayex Technology's earnings have been declining at an average annual rate of -38.9%, while the Healthcare Services industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 13.5% per year.

Informations clés

-38.9%

Taux de croissance des bénéfices

-30.1%

Taux de croissance du BPA

Healthcare Services Croissance de l'industrie	42.6%
Taux de croissance des recettes	-13.5%
Rendement des fonds propres	n/a
Marge nette	-103.1%
Dernière mise à jour des bénéfices	31 Dec 2023

Mises à jour récentes des performances passées

Recent updates

Ventilation des recettes et des dépenses

Comment Jayex Technology gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

CHIA:JTL Recettes, dépenses et bénéfices (AUD Millions )
Date	Recettes	Les revenus	Dépenses G+A
31 Dec 23	4	-4	2
30 Sep 23	4	-5	2
30 Jun 23	4	-6	2
31 Mar 23	4	-6	2
31 Dec 22	5	-6	2
30 Sep 22	5	-5	2
30 Jun 22	5	-3	2
31 Mar 22	5	-4	2
31 Dec 21	5	-4	2
30 Sep 21	4	-3	2
30 Jun 21	4	-3	1
31 Mar 21	5	-2	2
31 Dec 20	6	-1	2
30 Sep 20	6	-1	1
30 Jun 20	7	0	1
31 Mar 20	7	-1	1
31 Dec 19	7	-1	1
30 Sep 19	7	-1	1
30 Jun 19	7	-1	2
31 Mar 19	7	-1	2
31 Dec 18	7	-1	2
30 Sep 18	7	-1	2
30 Jun 18	7	-1	2
31 Mar 18	7	-2	2
31 Dec 17	8	-2	2
30 Sep 17	7	-4	2
30 Jun 17	7	-5	2
31 Mar 17	8	-5	2
31 Dec 16	9	-5	2
30 Jun 16	7	-4	2
31 Mar 16	4	-4	1
31 Dec 15	2	-3	1
30 Jun 15	1	-1	1
30 Jun 14	0	0	0

Des revenus de qualité: JTL is currently unprofitable.

Augmentation de la marge bénéficiaire: JTL is currently unprofitable.

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: JTL is unprofitable, and losses have increased over the past 5 years at a rate of 38.9% per year.

Accélération de la croissance: Unable to compare JTL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: JTL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.1%).

Rendement des fonds propres

ROE élevé: JTL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

This company listing is no longer active

Jayex Technology Résultats passés

Passé contrôle des critères 0/6

Informations clés

Mises à jour récentes des performances passées

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Recent updates

High number of new directors

Jayex Technology Limited Announces Board Changes

Jayex Technology Limited, Annual General Meeting, Jul 04, 2024

Less than half of directors are independent

Jayex Technology Limited Announces Directorate Changes

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

Jayex Technology Limited Announces Resignation of Nathan Woodard as Chief Financial Officer, Effective January 31, 2023

No independent directors

No independent directors

Jayex Technology Limited Announces Resignation of Michael Chan as Non-Executive Director

No independent directors

No independent directors

Jayex Technology Limited Appoints Robert Hadle as Chief Executive Officer, Effective 3 October 2022

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

No independent directors

No independent directors

No independent directors

Jayex Technology Limited, Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

No independent directors

Jayex Technology Limited has completed a Follow-on Equity Offering in the amount of AUD 0.572723 million.

Jayex Healthcare Limited announced that it expects to receive AUD 0.572723 million in funding

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Jayex Healthcare Limited, Annual General Meeting, May 27, 2021

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Jayex Healthcare Limited announced that it expects to receive AUD 0.7 million in funding

First half earnings released

Jayex Healthcare Limited Announces Resignation of Nick Fernando as Group Chief Executive Officer Effective 25 July 2020

Ventilation des recettes et des dépenses

Historique des gains et des recettes

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Rendement des fonds propres

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé